 This study is to assess the onset of action of fixed drug combination of azelastine hydrochloride and fluticasone propionate nasal spray MP-AzeFlu in treating the nasal symptoms of seasonal allergic rhinitis SAR induced by an allergen challenge in an Environmental Exposure Chamber EEC. 